Markus Reindl

Toll-like Receptor 4 Polymorphisms and Atherogenesis

Stefan Kiechl, Eva Lorenz, Markus Reindl et al. · New England Journal of Medicine · 2002 · 1K citations · Full text

Life Sciences, Genetics, Immunology +17

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

Sven Jarius, Klemens Ruprecht, Ingo Kleiter et al. · Journal of Neuroinflammation · 2016 · 891 citations · Full text

Medicine, Neurology, Neuroscience +15

Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia

Lisa Fellner, Regina Irschick, Kathrin Schanda et al. · Glia · 2012 · 708 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event

Thomas Berger, Paul Rubner, Franz Schautzer et al. · New England Journal of Medicine · 2003 · 624 citations · Full text

Life Sciences, Immunology, Neurology +17

Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo

Monika Bradl, Tatsuro Misu, Toshiyuki Takahashi et al. · Annals of Neurology · 2009 · 561 citations

Life Sciences, Neurology, Neuroscience +17